Peripheral B cell immune dysregulation genetically contributes to stage-dependent neuroinflammation and identifies priority therapeutic targets in Parkinson's disease: a computational integration of Mendelian randomization and single-cell transcriptomics
Front Med (Lausanne). 2026 Jun 9;13:1853077. doi: 10.3389/fmed.2026.1853077.
Article
Jun 25, 2026
Consortium publication
No